AU2002331468A1 - Oral pharmaceutical composition containing a combinaition of pparalpha and a hmg-coa reductase inhibitor - Google Patents

Oral pharmaceutical composition containing a combinaition of pparalpha and a hmg-coa reductase inhibitor

Info

Publication number
AU2002331468A1
AU2002331468A1 AU2002331468A AU2002331468A AU2002331468A1 AU 2002331468 A1 AU2002331468 A1 AU 2002331468A1 AU 2002331468 A AU2002331468 A AU 2002331468A AU 2002331468 A AU2002331468 A AU 2002331468A AU 2002331468 A1 AU2002331468 A1 AU 2002331468A1
Authority
AU
Australia
Prior art keywords
combinaition
pparalpha
hmg
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002331468A
Inventor
Philippe Baudier
Arthur Deboeck
Antonio Sereno
Francis Vanderbist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galephar MF
Original Assignee
Galephar MF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galephar MF filed Critical Galephar MF
Publication of AU2002331468A1 publication Critical patent/AU2002331468A1/en
Abandoned legal-status Critical Current

Links

AU2002331468A 2001-08-07 2002-08-07 Oral pharmaceutical composition containing a combinaition of pparalpha and a hmg-coa reductase inhibitor Abandoned AU2002331468A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU85616/01 2001-08-07
AU2001289428 2001-09-07

Publications (1)

Publication Number Publication Date
AU2002331468A1 true AU2002331468A1 (en) 2003-02-24

Family

ID=

Similar Documents

Publication Publication Date Title
AU6580000A (en) Pharmaceutical compositions comprising a hmg reductase inhibitor
HUP0104258A3 (en) Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
HUP0301087A3 (en) Oral pharmaceutical composition comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor
IL154977A0 (en) Statins (hmg-coa reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
AU2002310798A1 (en) Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
AU3591301A (en) Ester derivatives of dimethylpropionic acid and pharmacetuical compositions containing them
AU3368400A (en) Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammationassociated with pulmonary disease
GB9827391D0 (en) Aldose reductase inhibitors and pharmaceutical compositions
AU2003250172A1 (en) Compositions comprising hmg-coa reductase inhibitor
AU2003264859A1 (en) Intranasal pharmaceutical compositions comprising an antihistamine and a leukotriene inhibitor
AU2002223626A1 (en) Combinations of a thyromimetic compound and a statin
AU2003270154A1 (en) Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor
AU4543699A (en) Multibinding inhibitors of hmg-coa reductase
AU2003236636A1 (en) COMBINATION OF AN HMG-CoA REDUCTASE INHIBITOR AND A NITRATE ESTER
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2002252387A1 (en) Novel anti-inflammatory compositions and methods of use
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2003265373A1 (en) Preparation of aztreonam
AU2002331468A1 (en) Oral pharmaceutical composition containing a combinaition of pparalpha and a hmg-coa reductase inhibitor
AU2116201A (en) A therapeutic mixture of hmg-coa reductase inhibitors
HUP0303497A3 (en) Pharmaceutical compositions containing combination of statins and sorbitol dehydrogenase inhibitors
AU2001289428A1 (en) Oral pharmaceutical composition containing a combination of fenofibrate and a hmg-coa reductase inhibitor
AU2003292512A1 (en) Polyherbal preparation for the prevention of atherosclerosis and hyperlipidemia
AU2003252358A1 (en) MEDICINAL COMPOSITION CONTAINING HMG-CoA REDUCTASE INHIBITOR
HUP0301728A3 (en) Hmg-coa reductase inhibiting pharmaceutical compositions and their use